Condensed Consolidated and Combined Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities
Net income (loss)	$ 81,446	$ (5,733)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Bad debt expense	668	1,496
Depreciation and amortization	1,954	1,636
(Income) loss from equity method investments	(3,510)	2,966
Equity-based compensation	33,337	112,726
Deferred tax provision	595	(295)
Other	484	3,244
Changes in assets and liabilities:
Accounts receivable	(11,913)	4,738
Other receivables	(1,376)	(3,234)
Prepaid expenses and other assets	(2,397)	1,018
Deferred compensation	(2,863)	(1,181)
Compensation payable	(62,206)	(7,998)
Accounts payable and accrued expenses	(2,233)	7,667
Deferred revenue	1,925	484
Dividends received	2,473
Other liabilities	540	294
Net cash provided by (used in) operating activities	36,924	117,828
Cash flows from investing activities
Purchase of investments	(129,984)	(91,107)
Proceeds from sales of investments	57,000	83,237
Return of capital from equity method investments	221
Investment in equity method investments		(4,445)
Note payments received from employees		831
Notes issued to employees		(119)
Purchase of equipment and leasehold improvements	(2,902)	(2,381)
Change in restricted cash	(32)	(131)
Net cash provided by (used in) investing activities	(75,697)	(14,115)
Cash flows from financing activities
Pre-offering distribution to partners		(195,017)
Dividends and distributions	(64,394)	(57,884)
IPO related proceeds (net of $10,316 of offering costs)		163,682
Distributions of IPO proceeds to partners		(139,429)
Other cash contributions from (distributions to) Parent		(34,730)
Purchase of treasury stock	(7,006)
Cash proceeds from issuance of Class B common stock		500
Class A partnership units and other equity purchased	(90)
Excess tax benefits from equity-based compensation	449
Other		(938)
Net cash provided by (used in) financing activities	(71,041)	(263,816)
Effect of exchange rate fluctuations on cash and cash equivalents	(294)	(823)
Net increase (decrease) in cash and cash equivalents	(110,108)	(160,926)
Cash and cash equivalents, beginning of period	197,944	303,024
Cash and cash equivalents, end of period	87,836	142,098
Cash paid during the period for:
Income taxes	19,280	2,877
Other non-cash activity
Initial establishment of deferred tax assets, net of amounts payable		10,854
Capitalized offering costs paid in prior or subsequent period		1,575
Tax benefit related to settlement of appreciation units		4,308
Establishment of deferred tax asset related to reorganization		3,261
Increase in deferred tax asset related to IPO		1,302
Other non-cash distributions		$ 1,724
Class A Partnership Units or other equity converted into Class A Common Stock	4,478
Dividend equivalents issued	$ 2,732